The elmiric acids: biologically active anandamide analogs.
The elmiric acids: biologically active anandamide analogs.
批准号:
7894890
负责人:
SUMNER HOWARD BURSTEIN
金额:
$32.43万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-08-01 至 2012-01-31
关键词:
2-arachidonylglycerolAbbreviationsAbsence of pain sensationAcidsAcuteAdverse effectsAirAmidohydrolasesAnabolismAnti-Inflammatory AgentsAnti-inflammatoryApplications GrantsBindingBiologicalBiological AssayBiological ModelsBrainCNR1 geneCalcium ionCannabinoidsCategoriesCell Culture TechniquesCell physiologyCellsChemical StructureChemicalsChinese Hamster Ovary CellChronicCommunitiesDataDependencyDrug usageEndocannabinoidsEnzyme-Linked Immunosorbent AssayEnzymesExposure toFamilyFamily memberFibroblastsFutureGene SilencingGlycineGoalsHydrolysisImmunoassayIn VitroInflammationInflammatoryInflammatory ResponseInhibition of Cell ProliferationInjuryInterleukin-6InterleukinsLigandsLinkLipopolysaccharidesLipoxygenaseLiquid substanceMass Spectrum AnalysisMeasuresMediatingMediator of activation proteinMedicalModelingMolecularMusN-arachidonylglycineNamesNarcoticsNomenclatureNon-Steroidal Anti-Inflammatory AgentsNuclearOrphanPainPeritoneal FluidPeritonitisPharmaceutical PreparationsPhysiologicalPlatelet Activating FactorProceduresProstaglandin-Endoperoxide SynthaseProstaglandinsRattusReportingResearch SupportRheumatoid ArthritisRiskRoleSamplingScintillation CountingStructure-Activity RelationshipSuggestionSynovial CellSystemTNF geneTRPV1 geneTestingTetrahydrocannabinolThioglycolatesTimeTissuesTumor Necrosis Factor-alphaTumor Necrosis FactorsWorkaddictionajulemic acidamidaseanaloganandamidebasecapsaicin receptorcytokinefallsfatty acid amide hydrolasefollow-upgamma-Aminobutyric Acidgamma-Linolenic Acidglycine transporterhuman GPRC5C proteinin vitro Modelin vivoinhibitor/antagonistinnovationinsightinterestmembermonocytenovelperipheral bloodprogesterone 11-hemisuccinate-(2-iodohistamine)receptorresearch studyresponsesubcutaneous
中文摘要
作为一种化学物质,脂氨基酸已被人们认识了一段时间。然而,更多
最近,它们在哺乳动物中的存在和重要性已被发现。他们
似乎不仅在结构上与内源性大麻素有密切的关系,而且在
在生物作用方面。后者包括镇痛、消炎、
抑制细胞增殖和钙离子动员。到目前为止大约有40年了
已经确定了该家族的现有成员,此外,还有几个合成的
已经制备并研究了类似物。为了方便他们的身份识别,一个命名系统
根据榄香酸(EMA)的名字提出。典型的例子,N-花生四烯酰甘氨酸不与CBI结合,但它抑制甘氨酸转运体
GLYT2a,也似乎是孤儿G蛋白偶联受体GPRI8的配体。
它还可能通过其抑制作用而调节组织中的花生胺水平。
对FAAH的影响--介导去乙酰氨基酶失活的酶。其浓度集中在
大鼠的大脑比阿南达胺高几倍,这支持了它可能作为
生理调停者。未来的研究应该旨在阐明所有人的行为
这一有趣的分子家族的成员,并获得对可能的
行动机制。这些化合物的一个很有希望的用途是作为麻醉剂
替换剂。
英文摘要
As chemical entities, lipoamino acids have been known for some time. However, more
recently their occurrence and importance in mammalian species has been discovered. They
appear to have close relationships with the endocannabinoids not only structurally but also
in terms of biological actions. The latter include analgesia, anti-inflammatory effects,
inhibition of cell proliferation and calcium ion mobilization. To date about 40 naturally
occurring members of this family have been identified and, additionally, several synthetic
analogs have been prepared and studied. To facilitate their identity, a nomenclature system
has been suggested based on the name elmiric acid (EMA). The prototypic example, N-arachidonoyl glycine does not bind to CBI, however it does inhibit the glycine transporter
GLYT2a and also appears to be a ligand for the orphan G-protein-coupled receptor GPRI8.
It may also have a role in regulating tissue levels of anandamide by virtue of its inhibitory
effect on FAAH the enzyme that mediates inactivation of anandamide. Its concentration in
rat brain is several times higher than anandamide supporting its possible role as a
physiological mediator. Future studies should be aimed at elucidating the actions of all of
the members of this interesting family of molecules and gaining further insight into possible
mechanisms of action. A promising use for these compounds would be as narcotic
replacement agents.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The elmiric acids: biologically active anandamide analogs.
-
批准号:7727687
-
项目类别:
-
资助金额:$33.98万
-
财政年份:2009
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
Endocannabinoid Analogs as Anti-inflammatory Agents
-
批准号:7106374
-
项目类别:
-
资助金额:$11.86万
-
财政年份:2004
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
Endocannabinoid Analogs as Anti-inflammatory Agents
-
批准号:6951593
-
项目类别:
-
资助金额:$12.15万
-
财政年份:2004
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
Endocannabinoid Analogs as Anti-inflammatory Agents
-
批准号:6749403
-
项目类别:
-
资助金额:$12.15万
-
财政年份:2004
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
Endocannabinoid Analogs as Anti-inflammatory Agents
-
批准号:7678732
-
项目类别:
-
资助金额:$2.92万
-
财政年份:2004
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
NON PSYCHOACTIVE CANNABINOIDS WITH THERAPEUTIC POTENTIAL
-
批准号:6175550
-
项目类别:
-
资助金额:$23.86万
-
财政年份:1999
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
NON PSYCHOACTIVE CANNABINOIDS WITH THERAPEUTIC POTENTIAL
-
批准号:2902241
-
项目类别:
-
资助金额:$23.17万
-
财政年份:1999
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
NON PSYCHOACTIVE CANNABINOIDS WITH THERAPEUTIC POTENTIAL
-
批准号:6378830
-
项目类别:
-
资助金额:$24.58万
-
财政年份:1999
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
NON PSYCHOACTIVE CANNABINOIDS WITH THERAPEUTIC POTENTIAL
-
批准号:6515659
-
项目类别:
-
资助金额:$25.2万
-
财政年份:1999
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
BIOSYNTHESIS OF ANANDAMIDE--A NOVEL EICOSANOID
-
批准号:2122673
-
项目类别:
-
资助金额:$16.13万
-
财政年份:1995
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
ANANDAMIDE/THC INDUCED ARACHIDONIC ACID RELEASE
-
批准号:2121953
-
项目类别:
-
资助金额:$15.04万
-
财政年份:1995
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
ANANDAMIDE/THC INDUCED ARACHIDONIC ACID RELEASE
-
批准号:2377395
-
项目类别:
-
资助金额:$15.44万
-
财政年份:1995
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
BIOSYNTHESIS OF ANANDAMIDE--A NOVEL EICOSANOID
-
批准号:2122674
-
项目类别:
-
资助金额:$16.57万
-
财政年份:1995
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
ANANDAMIDE/THC INDUCED ARACHIDONIC ACID RELEASE
-
批准号:2882593
-
项目类别:
-
资助金额:$16.7万
-
财政年份:1995
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
ANANDAMIDE/THC INDUCED ARACHIDONIC ACID RELEASE
-
批准号:2121952
-
项目类别:
-
资助金额:$15.03万
-
财政年份:1995
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
BIOSYNTHESIS OF ANANDAMIDE--A NOVEL EICOSANOID
-
批准号:2443494
-
项目类别:
-
资助金额:$17.23万
-
财政年份:1995
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
ANANDAMIDE/THC INDUCED ARACHIDONIC ACID RELEASE
-
批准号:2668143
-
项目类别:
-
资助金额:$16.06万
-
财政年份:1995
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
PROSTAGLANDIN & CANNABIS
-
批准号:2116494
-
项目类别:
-
资助金额:$5.54万
-
财政年份:1977
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
PROSTAGLANDIN & CANNABIS
-
批准号:3207098
-
项目类别:
-
资助金额:$6.9万
-
财政年份:1977
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
BIOLOGICAL ACTIVITIES OF CANNABINOIDS
-
批准号:3207107
-
项目类别:
-
资助金额:$16.12万
-
财政年份:1977
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
海外基金